Managed care
Global Care Medical Group Ipa
Global Care Medical Group Ipa was paid $1.86M by Medicaid between Jan 2018 and Aug 2021, across 334 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.
33Billing provider infoGLOBAL CARE MEDICAL GROUP IPA
WOODLAND HILLS, CA 91367
WOODLAND HILLS, CA 91367
33aNPI1326171265assigned 03/13/2007
33bProvider typeHealth Maintenance Organization
28Total paid$1.86M
24GClaims332,710
24DCodes billed334
24AFirst – last monthJan 2018 – Aug 2021
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#31 of 151
Median peer was paid$59K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 133,955 | $673K | |
| 2019 | 6,635 | $36K | |
| 2020 | 79,509 | $523K | |
| 2021 | 112,611 | $631K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 11,397 | 10,609 | $241K |
| 99223 | Prolong inpt eval add15 m | 9.4% | 991 | 892 | $175K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.9% | 26,821 | 23,883 | $148K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.8% | 1,370 | 1,353 | $109K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.4% | 890 | 806 | $100K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.8% | 2,396 | 810 | $89K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.8% | 2,354 | 541 | $70K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 3.5% | 606 | 545 | $65K |
| S9083 | Global fee urgent care centers | 3.4% | 1,310 | 1,216 | $63K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.0% | 795 | 126 | $57K |
| 20553 | 1.8% | 510 | 474 | $34K | |
| 97039 | 1.8% | 991 | 374 | $33K |
322 more codes
| E0601 | Continuous positive airway pressure (cpap) device | 1.5% | 354 | $29K |
| 97803 | 1.5% | 1,274 | $28K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.5% | 6,053 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.5% | 6,129 | $27K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.4% | 1,085 | $26K |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 713 | $23K |
| 99205 | Prolong outpt/office vis | 1.1% | 145 | $21K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.1% | 524 | $21K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 1.1% | 357 | $20K |
| 97802 | 1.0% | 489 | $19K | |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 946 | $17K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 142 | $16K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,895 | $16K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | <1% | 574 | $15K |
| 92552 | <1% | 1,067 | $14K | |
| K0001 | Standard wheelchair | <1% | 295 | $14K |
| 92551 | <1% | 2,820 | $13K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 508 | $11K |
| 99221 | <1% | 494 | $11K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 22,052 | $11K |
| 95117 | <1% | 1,115 | $10K | |
| 81025 | <1% | 472 | $10K | |
| E0443 | Portable oxygen contents, gaseous, 1 month's supply = 1 unit | <1% | 206 | $10K |
| 81000 | <1% | 829 | $10K | |
| E0562 | Humidifier, heated, used with positive airway pressure device | <1% | 370 | $10K |
| V2020 | Frames, purchases | <1% | 398 | $8K |
| 80053 | Comprehensive metabolic panel | <1% | 19,495 | $8K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 628 | $8K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 463 | $7K |
| E0431 | Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing | <1% | 401 | $7K |
| 81002 | <1% | 1,041 | $7K | |
| 95144 | <1% | 45 | $7K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 582 | $6K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 199 | $6K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 593 | $6K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 269 | $6K |
| 92015 | Determination of refractive state | <1% | 706 | $6K |
| 93000 | <1% | 397 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 754 | $5K |
| 90686 | <1% | 837 | $5K | |
| 97162 | <1% | 103 | $5K | |
| 11721 | <1% | 153 | $5K | |
| A4649 | Surgical supply; miscellaneous | <1% | 228 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 424 | $4K |
| 97014 | <1% | 260 | $4K | |
| 99173 | <1% | 1,764 | $4K | |
| 99000 | <1% | 4,028 | $4K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 55 | $4K |
| 59425 | <1% | 156 | $4K | |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | <1% | 243 | $3K |
| 99285 | Emergency room visit (most serious) | <1% | 43 | $3K |
| 76857 | <1% | 74 | $3K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 55 | $3K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 47 | $3K |
| 85018 | <1% | 1,958 | $3K | |
| 99283 | Emergency room visit (moderate) | <1% | 66 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,119 | $3K |
| 99152 | <1% | 13 | $3K | |
| 20610 | <1% | 38 | $3K | |
| 62323 | <1% | 26 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 44 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,685 | $2K |
| 92133 | <1% | 108 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 403 | $2K |
| 51798 | <1% | 138 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,195 | $2K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | <1% | 26 | $2K |
| 92083 | <1% | 108 | $2K | |
| 82948 | <1% | 1,546 | $2K | |
| A4335 | Incontinence supply; miscellaneous | <1% | 216 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,859 | $2K |
| 92250 | <1% | 40 | $2K | |
| 80061 | Lipid panel | <1% | 12,727 | $2K |
| 88150 | <1% | 63 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 195 | $2K |
| 81001 | <1% | 9,230 | $2K | |
| 84484 | <1% | 1,368 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 134 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,204 | $1K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 55 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 314 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,407 | $1K |
| 85610 | <1% | 2,311 | $1K | |
| 92081 | <1% | 1,206 | $1K | |
| 94150 | <1% | 222 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,922 | $1K |
| 90651 | <1% | 209 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 367 | $1K |
| 72275 | <1% | 55 | $1K | |
| 85730 | <1% | 1,553 | $1K | |
| 90670 | <1% | 168 | $1K | |
| 83735 | <1% | 1,120 | $985.53 | |
| 83880 | <1% | 375 | $966.49 | |
| 90715 | <1% | 119 | $899.90 | |
| 83690 | <1% | 1,096 | $896.25 | |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | <1% | 12 | $872.45 |
| E0143 | Walker, folding, wheeled, adjustable or fixed height | <1% | 12 | $840.40 |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 13 | $782.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,263 | $778.36 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 152 | $720.30 |
| 99199 | Unlisted special service, procedure or report | <1% | 22 | $718.27 |
| 90734 | <1% | 112 | $669.84 | |
| 99442 | <1% | 6,084 | $636.32 | |
| 1036F | <1% | 3,650 | $596.62 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 16 | $566.64 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,572 | $553.55 |
| J3490 | Unclassified drugs | <1% | 37 | $551.17 |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | <1% | 52 | $547.39 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,032 | $546.16 |
| 90647 | <1% | 31 | $530.76 | |
| 90723 | <1% | 14 | $513.98 | |
| 85027 | <1% | 1,689 | $503.40 | |
| 81003 | <1% | 1,722 | $492.12 | |
| 3008F | <1% | 6,721 | $487.69 | |
| 86003 | <1% | 234 | $472.27 | |
| 92020 | <1% | 25 | $456.76 | |
| 82570 | <1% | 2,964 | $438.69 | |
| 99284 | Emergency room visit (serious) | <1% | 12 | $434.55 |
| 86803 | <1% | 1,205 | $430.61 | |
| 90658 | <1% | 174 | $385.92 | |
| 3079F | <1% | 580 | $368.84 | |
| 80076 | <1% | 589 | $352.56 | |
| 4004F | <1% | 149 | $338.47 | |
| A7038 | Filter, disposable, used with positive airway pressure device | <1% | 54 | $334.68 |
| 1111F | <1% | 2,400 | $323.18 | |
| 3078F | <1% | 4,604 | $323.11 | |
| 82550 | <1% | 567 | $319.42 | |
| 90633 | <1% | 77 | $312.04 | |
| A7035 | Headgear used with positive airway pressure device | <1% | 12 | $296.71 |
| 3077F | <1% | 564 | $272.05 | |
| 90621 | <1% | 31 | $272.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 330 | $269.83 |
| A7037 | Tubing used with positive airway pressure device | <1% | 12 | $265.88 |
| 83605 | <1% | 134 | $265.53 | |
| 82728 | <1% | 720 | $264.79 | |
| 85007 | <1% | 283 | $232.55 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 128 | $228.93 |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 95 | $225.27 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 689 | $225.04 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,354 | $221.51 |
| 80074 | <1% | 778 | $215.72 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 542 | $207.00 |
| 90656 | <1% | 101 | $203.30 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 62 | $197.10 |
| 84550 | <1% | 1,446 | $189.62 | |
| 1160F | <1% | 1,158 | $189.40 | |
| 51741 | <1% | 15 | $187.50 | |
| 86580 | <1% | 59 | $182.85 | |
| 84439 | <1% | 1,987 | $161.83 | |
| 86900 | <1% | 291 | $155.13 | |
| 84100 | <1% | 638 | $154.72 | |
| 87081 | <1% | 324 | $141.73 | |
| 86431 | <1% | 768 | $140.55 | |
| 83540 | <1% | 974 | $137.07 | |
| 82607 | <1% | 1,090 | $136.88 | |
| 82043 | <1% | 2,906 | $134.89 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 133 | $134.09 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 41 | $131.95 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 185 | $128.18 |
| 86140 | <1% | 973 | $120.98 | |
| 83550 | <1% | 755 | $120.17 | |
| 84155 | <1% | 191 | $112.50 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 239 | $111.88 |
| 86592 | <1% | 4,421 | $111.66 | |
| 3080F | <1% | 359 | $109.20 | |
| 36410 | <1% | 76 | $108.60 | |
| 90700 | <1% | 12 | $108.00 | |
| 3074F | <1% | 4,469 | $103.74 | |
| 82746 | <1% | 794 | $102.01 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 107 | $100.75 |
| 84703 | <1% | 305 | $99.00 | |
| 84436 | <1% | 1,566 | $97.39 | |
| 84702 | <1% | 412 | $95.31 | |
| 86901 | <1% | 206 | $91.02 | |
| 87340 | <1% | 1,005 | $90.47 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 15 | $83.75 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 201 | $81.00 |
| 86038 | <1% | 1,188 | $79.88 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,421 | $79.75 |
| 87186 | <1% | 459 | $78.16 | |
| 84153 | <1% | 946 | $74.18 | |
| 83655 | <1% | 787 | $72.58 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 319 | $70.64 |
| 83721 | <1% | 379 | $68.99 | |
| 87040 | <1% | 65 | $66.65 | |
| 87077 | <1% | 442 | $65.42 | |
| 92134 | <1% | 25 | $64.50 | |
| 86850 | <1% | 46 | $60.25 | |
| 90461 | <1% | 199 | $54.00 | |
| 84479 | <1% | 910 | $49.87 | |
| 86706 | <1% | 747 | $49.49 | |
| 96127 | <1% | 399 | $40.81 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 127 | $38.26 |
| 82378 | <1% | 93 | $37.73 | |
| 87088 | <1% | 1,594 | $37.25 | |
| 86235 | <1% | 107 | $35.50 | |
| 99348 | <1% | 37 | $34.30 | |
| 83615 | <1% | 38 | $28.37 | |
| 84481 | <1% | 850 | $28.23 | |
| 83001 | <1% | 272 | $28.00 | |
| 82140 | <1% | 14 | $27.72 | |
| 86480 | <1% | 282 | $27.52 | |
| 87070 | <1% | 512 | $27.47 | |
| 82248 | <1% | 786 | $27.05 | |
| 83026 | <1% | 31 | $27.00 | |
| 85652 | <1% | 1,384 | $26.58 | |
| 1157F | <1% | 34 | $24.00 | |
| 82785 | <1% | 147 | $23.21 | |
| 86704 | <1% | 651 | $22.53 | |
| 86039 | <1% | 313 | $22.21 | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 50 | $22.13 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 86 | $18.68 |
| 86200 | <1% | 233 | $18.63 | |
| 88142 | <1% | 231 | $18.13 | |
| 84403 | <1% | 162 | $18.06 | |
| 90688 | <1% | 59 | $18.00 | |
| 83002 | <1% | 226 | $17.97 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 62 | $17.68 |
| 86225 | <1% | 171 | $14.44 | |
| 86376 | <1% | 339 | $12.80 | |
| 86708 | <1% | 702 | $10.90 | |
| 85379 | <1% | 12 | $10.86 | |
| 82565 | <1% | 110 | $10.24 | |
| 90649 | <1% | 13 | $9.00 | |
| 3075F | <1% | 190 | $8.08 | |
| 84480 | <1% | 741 | $7.00 | |
| 82947 | <1% | 236 | $6.54 | |
| 82670 | <1% | 93 | $5.00 | |
| 84460 | <1% | 44 | $4.58 | |
| 85014 | <1% | 147 | $3.75 | |
| 82950 | <1% | 316 | $3.04 | |
| 84146 | <1% | 201 | $3.00 | |
| 80051 | <1% | 41 | $1.24 | |
| 1000F | 0% | 3,521 | $0.00 | |
| 96156 | 0% | 787 | $0.00 | |
| 87147 | 0% | 146 | $0.00 | |
| 86160 | 0% | 74 | $0.00 | |
| 86769 | 0% | 30 | $0.00 | |
| 1170F | 0% | 125 | $0.00 | |
| 82952 | 0% | 12 | $0.00 | |
| 1126F | 0% | 225 | $0.00 | |
| 94760 | 0% | 851 | $0.00 | |
| S9452 | Nutrition classes, non-physician provider, per session | 0% | 184 | $0.00 |
| 80081 | 0% | 201 | $0.00 | |
| 86593 | 0% | 43 | $0.00 | |
| 99058 | 0% | 65 | $0.00 | |
| 99443 | 0% | 374 | $0.00 | |
| 86695 | 0% | 253 | $0.00 | |
| 99441 | 0% | 321 | $0.00 | |
| 1125F | 0% | 78 | $0.00 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 0% | 96 | $0.00 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 255 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 160 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 12 | $0.00 |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 0% | 60 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 119 | $0.00 |
| 0012A | 0% | 137 | $0.00 | |
| 94200 | 0% | 96 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 26 | $0.00 |
| 88141 | 0% | 104 | $0.00 | |
| 0011A | 0% | 97 | $0.00 | |
| 83014 | 0% | 27 | $0.00 | |
| 2000F | 0% | 12 | $0.00 | |
| 86800 | 0% | 123 | $0.00 | |
| 97113 | 0% | 39 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 13 | $0.00 |
| 1034F | 0% | 29 | $0.00 | |
| 82962 | 0% | 15 | $0.00 | |
| 86780 | 0% | 29 | $0.00 | |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 59 | $0.00 |
| Q3014 | Telehealth originating site facility fee | 0% | 69 | $0.00 |
| 0001A | 0% | 42 | $0.00 | |
| 99406 | 0% | 30 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 26 | $0.00 |
| 95115 | 0% | 19 | $0.00 | |
| 3044F | 0% | 15 | $0.00 | |
| 86762 | 0% | 15 | $0.00 | |
| 82951 | 0% | 12 | $0.00 | |
| 90698 | 0% | 12 | $0.00 | |
| G0467 | Community health center visit, returning patient | 0% | 13 | $0.00 |
| 91301 | 0% | 34 | $0.00 | |
| 84520 | 0% | 74 | $0.00 | |
| 76642 | 0% | 130 | $0.00 | |
| 1090F | 0% | 148 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 135 | $0.00 |
| 99001 | 0% | 130 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 165 | $0.00 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 360 | $0.00 |
| A4550 | Surgical trays | 0% | 43 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 1,015 | $0.00 |
| 82274 | 0% | 592 | $0.00 | |
| 83013 | 0% | 277 | $0.00 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 0% | 523 | $0.00 |
| 1159F | 0% | 1,296 | $0.00 | |
| 98960 | 0% | 214 | $0.00 | |
| 96160 | 0% | 25 | $0.00 | |
| 99072 | 0% | 103 | $0.00 | |
| 82085 | 0% | 29 | $0.00 | |
| 87799 | 0% | 268 | $0.00 | |
| 82652 | 0% | 672 | $0.00 | |
| 84450 | 0% | 14 | $0.00 | |
| 99201 | 0% | 72 | $0.00 | |
| 87512 | 0% | 255 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 323 | $0.00 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 0% | 121 | $0.00 |
| 2014F | 0% | 40 | $0.00 | |
| 86318 | 0% | 55 | $0.00 | |
| 83970 | 0% | 85 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 151 | $0.00 |
| 3046F | 0% | 79 | $0.00 | |
| 86696 | 0% | 251 | $0.00 | |
| 36425 | 0% | 69 | $0.00 | |
| 83516 | 0% | 29 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 12 | $0.00 |
| 82465 | 0% | 12 | $0.00 | |
| 83525 | 0% | 17 | $0.00 | |
| 0002A | 0% | 41 | $0.00 | |
| 3725F | 0% | 59 | $0.00 | |
| S9470 | Nutritional counseling, dietitian visit | 0% | 43 | $0.00 |
| 86790 | 0% | 16 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 12 | $0.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEAKTOR, LINDA (DIRECTOR OF MEDICAL AFFAIRS)
| Provider | Location | Paid |
|---|---|---|
| Health Care LA, Ipa | Woodland Hills, CA | $10.89M |
| Bella Vista Medical Group Ipa | Woodland Hills, CA | $108K |
| Mission Community Ipa Medical Group | Woodland Hills, CA | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.